Cell line-derived tumor xenograft (CDX) models play an important role in basic research of tumorigenesis and metastasis, as well as drug development and treatment. Therefore, establishing a precise animal model is vital for accurate in vivo tumor studies and in advancing oncology research.
In this Exclusive Brief, we review the applications of cell line-derived tumor xenograft (CDX) models in tumor research.
Download this Exclusive Brief to discover how CDX models advance tumor research >>
With more than 15 years’ experience in genetic engineering, Cyagen offers a complete range of services to support tumor research, including: custom genetically engineered models, ready-to-use catalog models, drug development models, colony management, and phenotype analysis - allowing researchers worldwide to create, manage, and monitor models with ease.
In addition to animal model generation, Cyagen has established a range of supporting services, such as animal breeding, embryo/sperm cryopreservation, histology, and transcriptome profiling. Outsourcing these services to Cyagen is a more cost-effective way of conducting your research. All these services are performed by experienced specialists following standardized procedures, so we can guarantee delivery of high-quality services and data acquisition with unbeatable price and turnaround.